OCGN compared with TENX: revenue, margins and what each company keeps, and the suppliers and customers both name

OCGNOcugen, Inc.

Mkt capRevenueRevenue

TENXTenax Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

OCGNOcugen, Inc.

TENXTenax Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OCGN1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±22.9%▼−3.13%×0.14

TENX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−9.27%—

= impliedOCGN realized, solidTENX realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

OCGNOcugen, Inc.

0.74▲+5.42%

Mkt cap$238.3MRevenue$1MQ2 FY26Revenue$4MFY24

TENXTenax Therapeutics, Inc.

1.79▼−0.23%

Regular sessionNov 2 '26

Mkt cap$67.0MRevenue—Revenue—

Compare

Regular sessionNov 2 '26

OCGNOcugen, Inc.

TENXTenax Therapeutics, Inc.

0.74▲+5.42%

Price

1.79▼−0.23%

$238.3M

Mkt cap

$67.0M

Q2 FY26$1M

Revenue

—

FY24$4M

Revenue

—

OCGN0.74▲+5.42%vsTENX1.79▼−0.23%Regular sessionNov 2 '26